RevBio Expands Globally into the United Kingdom with its Second Cranial Flap Fixation Clinical Trial for its Regenerative Bone Adhesive

Contributed by: Business Wire

Logo

Images

Dr. Kumar Abhinav (left) and Dr. Mario Teo (right) have to date conducted three cases in the 15 patient clinical trial. The images above show the seamless restoration of cranial flaps using TETRANITE in this clinical trial.

Business Wire embedded0

Tags

Research

Surgery

Medical Devices

Neurology

Hospitals

Clinical Trials

Biotechnology

Health

Science

RevBio, Inc.

More Like This

RevBio initiates a pivotal clinical trial in Europe for its Dental Implant Stabilization product with 30 of 75 expected patient enrollments. Clinical Images courtesy of Prof. France Lambert of the University of Liege.

RevBio Initiates its Pivotal Clinical Trial in Europe for its Dental Implant Stabilization Product

Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market

Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures

The commercialization of Bioretec's RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement

Inside Information: Update for Bioretec's RemeOs™ Trauma Screw European Marketing Authorization

Inside information: Bioretec Ltd. receives CE mark approval for RemeOs™ Trauma Screw product portfolio, allowing market launch in Europe

Inside information: Bioretec's European market authorization for RemeOs trauma screw has proceeded to expert panel evaluation, the approval is estimated during the Q2 2024

PR Newswire associated0

Novadip Biosciences SA announces significant clinical milestones for both of its clinical-stage programs